Eris Lifesciences

BSE : 540596 | NSE : ERIS

Industry : Pharma Formulations | ISIN : INE406M01024 | FreeFloat : 10.00% | FnO : No | LotSize : N/A


Intellectual Capital (IC)6,473.85
Net Worth (NW)1,389.34
Intrinsic Worth (IW)7,863.19
Market Cap (MC)6,518.44
Economic Value Added28.74
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)82.33%
IC Gross Margin (EBITDA/IC)6.53%
IC Net Margin (NPT/IC)4.92%
Knowledge Turnover (Sales/IC)0.18
Market to Intrinsic Value (MC/IW)0.83

As OfIntrinsic ValueMarket Price
31 Dec 2019Rs. 571.79Rs. 474.00
22 May 2020 - Rs. 492.85
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : YesBuy10 DMA : Rs. 486.72BuyStrong Buy
KB > 50% : Yes50 DMA : Rs. 443.23
0 < M2IV < 1 : YesVol-Price trend : Rising

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Mar-17
C
159.14
158.40
61.83
54.35
40.24
40.94
41.12
Jun-17
C
185.21
192.08
71.43
66.81
73.67
70.84
70.84
Sep-17
C
249.23
255.68
97.76
92.50
98.93
93.15
93.15
Dec-17
C
208.97
214.75
81.10
74.41
77.43
74.92
74.92
Mar-18
C
212.19
219.50
79.03
69.97
62.21
56.08
56.51
Jun-18
C
250.76
254.29
92.08
84.80
77.70
71.56
71.56
Sep-18
C
264.18
270.34
106.84
98.56
92.31
85.51
85.63
Dec-18
C
252.40
262.68
103.81
94.22
89.11
80.20
80.26
Mar-19
C
214.82
226.55
73.88
62.67
58.24
53.88
53.59
Jun-19
C
274.30
277.13
107.34
95.83
94.92
84.06
83.67
Sep-19
C
284.79
289.96
115.02
103.28
102.77
92.71
92.63
Dec-19
C
266.40
274.87
85.25
72.55
72.16
63.47
63.40
* C - Consolidated, S - Standalone